D. Winston

Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.

G. Tricot, T. Reichert, S. Nimer, 1991, Transplantation proceedings.

Selective Depletion of CDS ' T Lymphocytes for Prevention of Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation

S. Feig, T. Reichert, J. Giorgi, 2003 .

Selective depletion of CD8 positive T-lymphocytes for prevention of graft-versus-host disease following allogeneic bone marrow transplantation.

S. Feig, T. Reichert, J. Giorgi, 1989, Transplantation proceedings.

Fluconazole Prophylaxis of Fungal Infections in Patients with Acute Leukemia: Results of a Randomized Placebo-Controlled, Double-Blind, Multicenter Trial

H. Horowitz, R. Shadduck, C. Rosenfeld, 1993, Annals of Internal Medicine.

Prevention of graft rejection following bone marrow transplantation.

S. Feig, J. Fahey, R. Gale, 1981, Blood.

Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial.

R. Elashoff, R. Elashoff, M. Selch, 1986, Annals of internal medicine.

Graft failure and leukemia relapse following T lymphocyte-depleted bone marrow transplants: effect of intensification of immunosuppressive conditioning.

S. Feig, R. Gale, R. Champlin, 1987, Transplantation proceedings.

Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.

S. Vollset, S. Nimer, G. Schiller, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevention of cytomegalovirus disease in transplant recipients

D. Winston, 1995, The Lancet.

Intravenous immunoglobulin in bone marrow transplantation

R. Gale, D. Winston, D. Winston, 1991, Cancer.